Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Other Gross PP&E Adjustments (2017 - 2025)

Haemonetics has reported Other Gross PP&E Adjustments over the past 16 years, most recently at $824.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 3.51% year-over-year to $824.5 million; the TTM value through Dec 2025 reached $824.5 million, down 3.51%, while the annual FY2025 figure was $837.2 million, 12.72% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $824.5 million at Haemonetics, up from $790.4 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $967.1 million in Q4 2023 and troughed at $756.0 million in Q2 2025.
  • A 5-year average of $879.7 million and a median of $889.3 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: increased 8.64% in 2023 and later fell 16.88% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $817.3 million in 2021, then grew by 6.35% to $869.1 million in 2022, then grew by 11.27% to $967.1 million in 2023, then dropped by 11.65% to $854.5 million in 2024, then decreased by 3.51% to $824.5 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for HAE at $824.5 million in Q4 2025, $790.4 million in Q3 2025, and $756.0 million in Q2 2025.